世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

非オピオイド鎮痛薬-世界市場シェアとランキング、全体売上高と需要予測 2025-2031

非オピオイド鎮痛薬-世界市場シェアとランキング、全体売上高と需要予測 2025-2031


Non-opioid Analgesics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

非オピオイド鎮痛薬の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。 非オピオイド鎮痛薬の北... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2025年3月21日 US$3,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

非オピオイド鎮痛薬の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。

非オピオイド鎮痛薬の北米市場は、2024年に百万米ドルと評価され、2025年から2031年の予測期間中に%のCAGRで、2031年までに百万米ドルに達すると予測されています。
非オピオイド鎮痛薬のアジア太平洋市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に%のCAGRで、2031年までに100万ドルに達する見込みです。
非オピオイド鎮痛薬のヨーロッパ市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に年平均成長率%で、2031年には100万ドルに達する見込みです。

非オピオイド鎮痛薬の世界の主要企業には、AbbVie Inc.、Pfizer, Inc.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Centrexion Therapeutics、Cara Therapeutics、Medropharm GmbHなどがあります。2024年には、世界の大手5社が売上高で約 %のシェアを占めています。
本レポートは、非オピオイド鎮痛薬の世界市場を包括的に紹介することを目的としており、非オピオイド鎮痛薬の地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングに焦点を当てています。

非オピオイド鎮痛剤の市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データとともに、販売数量(K単位)と販売収益(百万ドル)で提供されます。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、非オピオイド鎮痛薬に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。

市場区分
企業別
アッヴィ社
ファイザー
テバ・ファーマシューティカル・インダストリーズ
ヴィアトリス
セントレクシオン・セラピューティクス
カラ・セラピューティクス
Medropharm GmbH.
タイプ別セグメント
非ステロイド性抗炎症薬
アセトアミノフェン
局所麻酔薬
用途別セグメント
病院薬局
小売薬局
オンライン薬局
地域別
北米
米国
カナダ
アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア太平洋地域
ヨーロッパ
ドイツ
フランス
英国
イタリア
オランダ
北欧諸国
その他のヨーロッパ
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章: レポートの対象範囲、世界の総市場規模(金額、数量、価格)を紹介します。また本章では、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。
第2章:非オピオイド鎮痛薬メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。
第3章:各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模と発展可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。
第4章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。
第5章:非オピオイド鎮痛薬の地域別売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介しています。
第6章 非オピオイド鎮痛薬の国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。
第7章:主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。
第8章:産業の上流と下流を含む産業チェーンの分析。
第9章:結論


ページTOPに戻る


目次

1 Market Overview
1.1 Non-opioid Analgesics Product Introduction
1.2 Global Non-opioid Analgesics Market Size Forecast
1.2.1 Global Non-opioid Analgesics Sales Value (2020-2031)
1.2.2 Global Non-opioid Analgesics Sales Volume (2020-2031)
1.2.3 Global Non-opioid Analgesics Sales Price (2020-2031)
1.3 Non-opioid Analgesics Market Trends & Drivers
1.3.1 Non-opioid Analgesics Industry Trends
1.3.2 Non-opioid Analgesics Market Drivers & Opportunity
1.3.3 Non-opioid Analgesics Market Challenges
1.3.4 Non-opioid Analgesics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-opioid Analgesics Players Revenue Ranking (2024)
2.2 Global Non-opioid Analgesics Revenue by Company (2020-2025)
2.3 Global Non-opioid Analgesics Players Sales Volume Ranking (2024)
2.4 Global Non-opioid Analgesics Sales Volume by Company Players (2020-2025)
2.5 Global Non-opioid Analgesics Average Price by Company (2020-2025)
2.6 Key Manufacturers Non-opioid Analgesics Manufacturing Base and Headquarters
2.7 Key Manufacturers Non-opioid Analgesics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-opioid Analgesics
2.9 Non-opioid Analgesics Market Competitive Analysis
2.9.1 Non-opioid Analgesics Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-opioid Analgesics Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Analgesics as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 NSAIDs
3.1.2 Acetaminophen
3.1.3 Local Anesthetics
3.2 Global Non-opioid Analgesics Sales Value by Type
3.2.1 Global Non-opioid Analgesics Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Non-opioid Analgesics Sales Value, by Type (2020-2031)
3.2.3 Global Non-opioid Analgesics Sales Value, by Type (%) (2020-2031)
3.3 Global Non-opioid Analgesics Sales Volume by Type
3.3.1 Global Non-opioid Analgesics Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Non-opioid Analgesics Sales Volume, by Type (2020-2031)
3.3.3 Global Non-opioid Analgesics Sales Volume, by Type (%) (2020-2031)
3.4 Global Non-opioid Analgesics Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Non-opioid Analgesics Sales Value by Application
4.2.1 Global Non-opioid Analgesics Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Non-opioid Analgesics Sales Value, by Application (2020-2031)
4.2.3 Global Non-opioid Analgesics Sales Value, by Application (%) (2020-2031)
4.3 Global Non-opioid Analgesics Sales Volume by Application
4.3.1 Global Non-opioid Analgesics Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Non-opioid Analgesics Sales Volume, by Application (2020-2031)
4.3.3 Global Non-opioid Analgesics Sales Volume, by Application (%) (2020-2031)
4.4 Global Non-opioid Analgesics Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Non-opioid Analgesics Sales Value by Region
5.1.1 Global Non-opioid Analgesics Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Non-opioid Analgesics Sales Value by Region (2020-2025)
5.1.3 Global Non-opioid Analgesics Sales Value by Region (2026-2031)
5.1.4 Global Non-opioid Analgesics Sales Value by Region (%), (2020-2031)
5.2 Global Non-opioid Analgesics Sales Volume by Region
5.2.1 Global Non-opioid Analgesics Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Non-opioid Analgesics Sales Volume by Region (2020-2025)
5.2.3 Global Non-opioid Analgesics Sales Volume by Region (2026-2031)
5.2.4 Global Non-opioid Analgesics Sales Volume by Region (%), (2020-2031)
5.3 Global Non-opioid Analgesics Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Non-opioid Analgesics Sales Value, 2020-2031
5.4.2 North America Non-opioid Analgesics Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Non-opioid Analgesics Sales Value, 2020-2031
5.5.2 Europe Non-opioid Analgesics Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Non-opioid Analgesics Sales Value, 2020-2031
5.6.2 Asia Pacific Non-opioid Analgesics Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Non-opioid Analgesics Sales Value, 2020-2031
5.7.2 South America Non-opioid Analgesics Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-opioid Analgesics Sales Value, 2020-2031
5.8.2 Middle East & Africa Non-opioid Analgesics Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-opioid Analgesics Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Non-opioid Analgesics Sales Value
6.2.1 Key Countries/Regions Non-opioid Analgesics Sales Value, 2020-2031
6.2.2 Key Countries/Regions Non-opioid Analgesics Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Non-opioid Analgesics Sales Value, 2020-2031
6.3.2 United States Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Non-opioid Analgesics Sales Value, 2020-2031
6.4.2 Europe Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Non-opioid Analgesics Sales Value, 2020-2031
6.5.2 China Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.5.3 China Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Non-opioid Analgesics Sales Value, 2020-2031
6.6.2 Japan Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Non-opioid Analgesics Sales Value, 2020-2031
6.7.2 South Korea Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Non-opioid Analgesics Sales Value, 2020-2031
6.8.2 Southeast Asia Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Non-opioid Analgesics Sales Value, 2020-2031
6.9.2 India Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.9.3 India Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Company Information
7.1.2 AbbVie Inc Introduction and Business Overview
7.1.3 AbbVie Inc Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 AbbVie Inc Non-opioid Analgesics Product Offerings
7.1.5 AbbVie Inc Recent Development
7.2 Pfizer, Inc
7.2.1 Pfizer, Inc Company Information
7.2.2 Pfizer, Inc Introduction and Business Overview
7.2.3 Pfizer, Inc Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Pfizer, Inc Non-opioid Analgesics Product Offerings
7.2.5 Pfizer, Inc Recent Development
7.3 Teva Pharmaceutical Industries Ltd.
7.3.1 Teva Pharmaceutical Industries Ltd. Company Information
7.3.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
7.3.3 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product Offerings
7.3.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.4 Viatris Inc.
7.4.1 Viatris Inc. Company Information
7.4.2 Viatris Inc. Introduction and Business Overview
7.4.3 Viatris Inc. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Viatris Inc. Non-opioid Analgesics Product Offerings
7.4.5 Viatris Inc. Recent Development
7.5 Centrexion Therapeutics
7.5.1 Centrexion Therapeutics Company Information
7.5.2 Centrexion Therapeutics Introduction and Business Overview
7.5.3 Centrexion Therapeutics Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Centrexion Therapeutics Non-opioid Analgesics Product Offerings
7.5.5 Centrexion Therapeutics Recent Development
7.6 Cara Therapeutics
7.6.1 Cara Therapeutics Company Information
7.6.2 Cara Therapeutics Introduction and Business Overview
7.6.3 Cara Therapeutics Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Cara Therapeutics Non-opioid Analgesics Product Offerings
7.6.5 Cara Therapeutics Recent Development
7.7 Medropharm GmbH.
7.7.1 Medropharm GmbH. Company Information
7.7.2 Medropharm GmbH. Introduction and Business Overview
7.7.3 Medropharm GmbH. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Medropharm GmbH. Non-opioid Analgesics Product Offerings
7.7.5 Medropharm GmbH. Recent Development
8 Industry Chain Analysis
8.1 Non-opioid Analgesics Industrial Chain
8.2 Non-opioid Analgesics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-opioid Analgesics Sales Model
8.5.2 Sales Channel
8.5.3 Non-opioid Analgesics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る


 

Summary

The global market for Non-opioid Analgesics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Non-opioid Analgesics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non-opioid Analgesics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Non-opioid Analgesics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Non-opioid Analgesics include AbbVie Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Centrexion Therapeutics, Cara Therapeutics, Medropharm GmbH., etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Non-opioid Analgesics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-opioid Analgesics by region & country, by Type, and by Application.

The Non-opioid Analgesics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Analgesics.

Market Segmentation
By Company
AbbVie Inc
Pfizer, Inc
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Centrexion Therapeutics
Cara Therapeutics
Medropharm GmbH.
Segment by Type
NSAIDs
Acetaminophen
Local Anesthetics
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-opioid Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Non-opioid Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Non-opioid Analgesics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.



ページTOPに戻る


Table of Contents

1 Market Overview
1.1 Non-opioid Analgesics Product Introduction
1.2 Global Non-opioid Analgesics Market Size Forecast
1.2.1 Global Non-opioid Analgesics Sales Value (2020-2031)
1.2.2 Global Non-opioid Analgesics Sales Volume (2020-2031)
1.2.3 Global Non-opioid Analgesics Sales Price (2020-2031)
1.3 Non-opioid Analgesics Market Trends & Drivers
1.3.1 Non-opioid Analgesics Industry Trends
1.3.2 Non-opioid Analgesics Market Drivers & Opportunity
1.3.3 Non-opioid Analgesics Market Challenges
1.3.4 Non-opioid Analgesics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-opioid Analgesics Players Revenue Ranking (2024)
2.2 Global Non-opioid Analgesics Revenue by Company (2020-2025)
2.3 Global Non-opioid Analgesics Players Sales Volume Ranking (2024)
2.4 Global Non-opioid Analgesics Sales Volume by Company Players (2020-2025)
2.5 Global Non-opioid Analgesics Average Price by Company (2020-2025)
2.6 Key Manufacturers Non-opioid Analgesics Manufacturing Base and Headquarters
2.7 Key Manufacturers Non-opioid Analgesics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-opioid Analgesics
2.9 Non-opioid Analgesics Market Competitive Analysis
2.9.1 Non-opioid Analgesics Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-opioid Analgesics Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Analgesics as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 NSAIDs
3.1.2 Acetaminophen
3.1.3 Local Anesthetics
3.2 Global Non-opioid Analgesics Sales Value by Type
3.2.1 Global Non-opioid Analgesics Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Non-opioid Analgesics Sales Value, by Type (2020-2031)
3.2.3 Global Non-opioid Analgesics Sales Value, by Type (%) (2020-2031)
3.3 Global Non-opioid Analgesics Sales Volume by Type
3.3.1 Global Non-opioid Analgesics Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Non-opioid Analgesics Sales Volume, by Type (2020-2031)
3.3.3 Global Non-opioid Analgesics Sales Volume, by Type (%) (2020-2031)
3.4 Global Non-opioid Analgesics Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Non-opioid Analgesics Sales Value by Application
4.2.1 Global Non-opioid Analgesics Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Non-opioid Analgesics Sales Value, by Application (2020-2031)
4.2.3 Global Non-opioid Analgesics Sales Value, by Application (%) (2020-2031)
4.3 Global Non-opioid Analgesics Sales Volume by Application
4.3.1 Global Non-opioid Analgesics Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Non-opioid Analgesics Sales Volume, by Application (2020-2031)
4.3.3 Global Non-opioid Analgesics Sales Volume, by Application (%) (2020-2031)
4.4 Global Non-opioid Analgesics Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Non-opioid Analgesics Sales Value by Region
5.1.1 Global Non-opioid Analgesics Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Non-opioid Analgesics Sales Value by Region (2020-2025)
5.1.3 Global Non-opioid Analgesics Sales Value by Region (2026-2031)
5.1.4 Global Non-opioid Analgesics Sales Value by Region (%), (2020-2031)
5.2 Global Non-opioid Analgesics Sales Volume by Region
5.2.1 Global Non-opioid Analgesics Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Non-opioid Analgesics Sales Volume by Region (2020-2025)
5.2.3 Global Non-opioid Analgesics Sales Volume by Region (2026-2031)
5.2.4 Global Non-opioid Analgesics Sales Volume by Region (%), (2020-2031)
5.3 Global Non-opioid Analgesics Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Non-opioid Analgesics Sales Value, 2020-2031
5.4.2 North America Non-opioid Analgesics Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Non-opioid Analgesics Sales Value, 2020-2031
5.5.2 Europe Non-opioid Analgesics Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Non-opioid Analgesics Sales Value, 2020-2031
5.6.2 Asia Pacific Non-opioid Analgesics Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Non-opioid Analgesics Sales Value, 2020-2031
5.7.2 South America Non-opioid Analgesics Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-opioid Analgesics Sales Value, 2020-2031
5.8.2 Middle East & Africa Non-opioid Analgesics Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-opioid Analgesics Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Non-opioid Analgesics Sales Value
6.2.1 Key Countries/Regions Non-opioid Analgesics Sales Value, 2020-2031
6.2.2 Key Countries/Regions Non-opioid Analgesics Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Non-opioid Analgesics Sales Value, 2020-2031
6.3.2 United States Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Non-opioid Analgesics Sales Value, 2020-2031
6.4.2 Europe Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Non-opioid Analgesics Sales Value, 2020-2031
6.5.2 China Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.5.3 China Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Non-opioid Analgesics Sales Value, 2020-2031
6.6.2 Japan Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Non-opioid Analgesics Sales Value, 2020-2031
6.7.2 South Korea Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Non-opioid Analgesics Sales Value, 2020-2031
6.8.2 Southeast Asia Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Non-opioid Analgesics Sales Value, 2020-2031
6.9.2 India Non-opioid Analgesics Sales Value by Type (%), 2024 VS 2031
6.9.3 India Non-opioid Analgesics Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Company Information
7.1.2 AbbVie Inc Introduction and Business Overview
7.1.3 AbbVie Inc Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 AbbVie Inc Non-opioid Analgesics Product Offerings
7.1.5 AbbVie Inc Recent Development
7.2 Pfizer, Inc
7.2.1 Pfizer, Inc Company Information
7.2.2 Pfizer, Inc Introduction and Business Overview
7.2.3 Pfizer, Inc Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Pfizer, Inc Non-opioid Analgesics Product Offerings
7.2.5 Pfizer, Inc Recent Development
7.3 Teva Pharmaceutical Industries Ltd.
7.3.1 Teva Pharmaceutical Industries Ltd. Company Information
7.3.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
7.3.3 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product Offerings
7.3.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.4 Viatris Inc.
7.4.1 Viatris Inc. Company Information
7.4.2 Viatris Inc. Introduction and Business Overview
7.4.3 Viatris Inc. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Viatris Inc. Non-opioid Analgesics Product Offerings
7.4.5 Viatris Inc. Recent Development
7.5 Centrexion Therapeutics
7.5.1 Centrexion Therapeutics Company Information
7.5.2 Centrexion Therapeutics Introduction and Business Overview
7.5.3 Centrexion Therapeutics Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Centrexion Therapeutics Non-opioid Analgesics Product Offerings
7.5.5 Centrexion Therapeutics Recent Development
7.6 Cara Therapeutics
7.6.1 Cara Therapeutics Company Information
7.6.2 Cara Therapeutics Introduction and Business Overview
7.6.3 Cara Therapeutics Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Cara Therapeutics Non-opioid Analgesics Product Offerings
7.6.5 Cara Therapeutics Recent Development
7.7 Medropharm GmbH.
7.7.1 Medropharm GmbH. Company Information
7.7.2 Medropharm GmbH. Introduction and Business Overview
7.7.3 Medropharm GmbH. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Medropharm GmbH. Non-opioid Analgesics Product Offerings
7.7.5 Medropharm GmbH. Recent Development
8 Industry Chain Analysis
8.1 Non-opioid Analgesics Industrial Chain
8.2 Non-opioid Analgesics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-opioid Analgesics Sales Model
8.5.2 Sales Channel
8.5.3 Non-opioid Analgesics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/02 10:26

150.84 円

163.21 円

197.52 円

ページTOPに戻る